作者

Tasmina Goraya, PhD

合伙人

Read More

Katie Chandler

合伙人

Read More

Dr. Anja Lunze, LL.M.

合伙人

Read More

Paul England, DPhil

高级专业支持律师

Read More

Agnieszka Sztoldman

高级律师

Read More
作者

Tasmina Goraya, PhD

合伙人

Read More

Katie Chandler

合伙人

Read More

Dr. Anja Lunze, LL.M.

合伙人

Read More

Paul England, DPhil

高级专业支持律师

Read More

Agnieszka Sztoldman

高级律师

Read More

2020年2月20日

National perspectives on the CJEU Bayer decision

This month in Synapse

National perspectives on the CJEU Bayer decision

Our European team looks at what the CJEU decision in case C-688/17 may mean for national practice.

Medical devices and managing product liability risks

We look at medical device product liability, starting with an incident report to a regulator and following the potential issues that a manufacturer might face.

Clash of IP and competition to pharma's detriment? The CJEU's decision in theGSK case

Paolo Parmigiano and Barbora Dubanská explore the latest CJEU judgment in relation to pay-for-delay settlement agreements.

To Neurim or not to Neurim, that is the question

Anja Lunze examines what the Opinion of Advocate General Giovanni Pitruzella says concerning supplementary protection certificates.

Changes in the industrial property law of Poland

Kalina Skwiecińska and Agnieszka Sztoldman provide an overview of the changes to Polish industrial property law that recently came into effect.

Pricing: highlights of the J.P. Morgan Healthcare Conference

Barbora Dubanská reports on what the conference had to say about a major healthcare hot topic – drug pricing.

Patents diary: February 2020

A CRISPR Cas9 patent has its priority rejected by the Technical Board of Appeal, and there is a rare and successful application of the Crown use defence to infringement in the UK.

Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

技术、媒体与通信 (TMC)

'Femtech' – regulatory considerations

2021年10月29日
In-depth analysis

作者 Tasmina Goraya, PhD

点击此处了解更多
酒店与休闲

UK medicines – Is the Northern Ireland Protocol now unsustainable?

2021年10月14日
Quick read

作者 Paul England, DPhil

点击此处了解更多
专利与创新

The UK and the Trans-Pacific Partnership – Could patent conflicts ruin the deal?

Available in English and Japanese

2021年8月31日
Briefing

作者 Paul England, DPhil

点击此处了解更多